- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06943716
Efficacy of Bilateral Modified Catheter Antegrade Cerebral Perfusion in Acute Type A Aortic Dissection Surgery
A Retrospective Cohort Study Evaluating the Efficacy of Bilateral Modified Catheter Antegrade Cerebral Perfusion (Modified bACP) in Acute Type A Aortic Dissection Surgery
Study Overview
Status
Conditions
Detailed Description
Background and Rationale Acute Type A aortic dissection (ATAAD) is a life-threatening condition requiring urgent surgical repair. Prolonged circulatory arrest increases the risk of neurological complications. Bilateral antegrade cerebral perfusion (bACP) has shown potential to reduce ischemic injury. However, conventional bACP requires additional surgical access. This study examines a Modified bACP approach that may reduce surgical trauma while maintaining adequate cerebral perfusion.
Objectives This retrospective cohort study evaluates whether Modified bACP improves postoperative outcomes compared to conventional perfusion strategies in ATAAD surgery at China Medical University Hospital (2021/1/1-2024/10/31).
Methods We will collect and analyze medical records of adult patients who underwent ATAAD repair, comparing those who received Modified bACP to those managed with conventional perfusion.
Outcome Measures
Primary Outcomes:
In-hospital mortality 30-day mortality
Secondary Outcomes:
Hospital length of stay (day) ICU length of stay (day) Mechanical ventilation duration (hours) Need for tracheostomy Stroke Postoperative neurological deficit Paraplegia Coma Atrial fibrillation (Af) Myocardial infarction Acute kidney injury (AKI) Dialysis requirement Reoperation for bleeding Sepsis Significance This study aims to provide comprehensive data on the safety and efficacy of Modified bACP in ATAAD surgery, potentially improving neurological protection and reducing other major complications and resource utilization. The findings may guide clinical practice and inform future protocol developments.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Taichung City, Taiwan, 40447
- China Medical University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adults (≥ 18 years old) who underwent acute Type A aortic dissection repair at China Medical University Hospital between January 1, 2021, and October 31, 2024.
Exclusion Criteria:
- Preexisting severe neurological impairment (e.g., stroke or other major neurological deficits before surgery).
- Age < 18 years.
- Pregnant patients.
- Insufficient or missing medical records preventing data analysis.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Modified bACP Group
Patients who underwent acute Type A aortic dissection repair using the Bilateral Modified Catheter Antegrade Cerebral Perfusion (Modified bACP) technique.
This observational group received the modified perfusion strategy aimed at reducing surgical trauma and enhancing cerebral protection.
|
A modified bilateral catheter antegrade cerebral perfusion technique used for acute Type A aortic dissection repair.
This approach aims to reduce surgical trauma by avoiding additional right axillary access while maintaining stable cerebral perfusion.
|
|
Conventional Perfusion Group
Patients who underwent acute Type A aortic dissection repair using the conventional brain perfusion technique (e.g., standard bilateral antegrade cerebral perfusion).
This group serves as the comparison cohort for evaluating the effects of the modified technique.
|
Patients receiving the conventional perfusion strategy for aortic arch surgery, which may include standard bilateral ACP based on the surgeon's preference and the patient's condition.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stroke
Time Frame: Through hospital discharge (on average about 14 days post-surgery)
|
New-onset cerebrovascular accident or imaging-confirmed stroke during hospitalization.
|
Through hospital discharge (on average about 14 days post-surgery)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative Neurological Deficit
Time Frame: Through hospital discharge (on average about 14 days post-surgery)
|
Any persistent neurological deficit (e.g., motor/sensory deficits) identified after surgery.
|
Through hospital discharge (on average about 14 days post-surgery)
|
|
30-day Mortality
Time Frame: Assessed at 30 days post-surgery
|
All-cause mortality occurring within 30 days after the surgical procedure.
|
Assessed at 30 days post-surgery
|
|
Hospital Stay (day)
Time Frame: From end of surgery to hospital discharge (up to 21 days).
|
Total number of days from the operation date to the date of hospital discharge.
|
From end of surgery to hospital discharge (up to 21 days).
|
|
ICU Stay (day)
Time Frame: From end of surgery to ICU discharge (up to 10 days).
|
Length of stay in the intensive care unit after surgery.
|
From end of surgery to ICU discharge (up to 10 days).
|
|
Mechanical Ventilation (hour)
Time Frame: From end of surgery until extubation (up to 72 hours).
|
Duration of mechanical ventilation in hours.
|
From end of surgery until extubation (up to 72 hours).
|
|
Acute Kidney Injury (AKI)
Time Frame: During the index hospitalization (on average about 10-14 days post-surgery)
|
Acute kidney injury defined by changes in serum creatinine or urine output (e.g., KDIGO criteria).
|
During the index hospitalization (on average about 10-14 days post-surgery)
|
|
Dialysis Requirement
Time Frame: During the index hospitalization (on average about 10-14 days post-surgery)
|
Proportion of patients requiring renal replacement therapy (dialysis) postoperatively.
|
During the index hospitalization (on average about 10-14 days post-surgery)
|
|
Reoperation for Bleeding
Time Frame: During the index hospitalization (on average about 72 hours post-surgery)
|
Number of patients requiring a return to the operating room for bleeding control or hematoma.
|
During the index hospitalization (on average about 72 hours post-surgery)
|
|
Sepsis
Time Frame: During the index hospitalization (on average within 7 days post-surgery)
|
Incidence of sepsis as defined by current guidelines (e.g., Sepsis-3), typically requiring positive cultures and organ dysfunction.
|
During the index hospitalization (on average within 7 days post-surgery)
|
|
Atrial Fibrillation (Af)
Time Frame: During the index hospitalization (on average within 7 days post-surgery)
|
New-onset atrial fibrillation or documented arrhythmia episodes requiring clinical management.
|
During the index hospitalization (on average within 7 days post-surgery)
|
|
Myocardial Infarction
Time Frame: During the index hospitalization (on average about 10-14 days post-surgery)
|
Clinically confirmed myocardial infarction based on ECG changes, cardiac enzymes, and clinical symptoms.
|
During the index hospitalization (on average about 10-14 days post-surgery)
|
Collaborators and Investigators
Investigators
- Principal Investigator: En-Bo Wu, M.D., Department of Anesthesiology, China Medical University Hospital, China Medical University, Taichung City 404, Taiwan
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CMUH113-REC1-183 (Other Identifier: Institutional Review Board, China Medical University Hospital)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Type A Aortic Dissection
-
Second Affiliated Hospital, School of Medicine,...Tongji Hospital; The Affiliated Hospital of Qingdao University; The Affiliated... and other collaboratorsNot yet recruitingStanford Type A Aortic Dissection | Acute Type A Aortic Dissection | Postoperative Aortic Dissection Follow-up
-
China Medical University HospitalCompletedAcute Type A Aortic DissectionTaiwan
-
Yusuf ShiebaCompletedAcute Type A Aortic DissectionEgypt
-
China-Japan Friendship HospitalNot yet recruitingAcute Type A Aortic DissectionChina
-
Centre Hospitalier Universitaire DijonRecruitingType A Aortic Dissection With Residual Type B Dissection | Chronic Type B Aortic DissectionFrance
-
The First Hospital of Hebei Medical UniversityCompletedAcute Stanford Type A Aortic DissectionChina
-
JOTEC GmbHActive, not recruitingAortic Dissection | Intramural Hematoma | Acute DeBakey I Dissection | Acute Type A DissectionGermany
-
Centre Cardiologique du NordUniversita degli Studi di Genova; Campus Bio-Medico University; Henri Mondor... and other collaboratorsEnrolling by invitationAortic Valve Insufficiency | Type B Aortic Dissection | Aortic Diseases | Ascending Aortic Dissection | Aortic Arch | Aortic Root Dissection | Aortic Root Dilatation | Type A Aortic DissectionFrance
-
Nanjing Medical UniversityBeijing Anzhen HospitalCompletedAcute Aortic Syndrome | Type a Aortic DissectionChina
-
Helsinki University Central HospitalAssistance Publique - Hôpitaux de Paris; Universitaire Ziekenhuizen KU Leuven; Azienda Ospedaliera Universitaria Integrata Verona and other collaboratorsCompletedType A Aortic DissectionSpain, Belgium, Finland, United Kingdom, Germany, Italy, Czechia, France
Clinical Trials on Modified Catheter Antegrade Cerebral Perfusion (Modified bACP)
-
China Medical University HospitalCompletedAcute Type A Aortic DissectionTaiwan
-
Emory UniversityChildren's Healthcare of AtlantaCompletedAortic Arch Hypoplasia or AtresiaUnited States
-
UMC UtrechtCompletedHypoplastic Left Heart Syndrome | Aortic Coarctation | Congenital Heart DefectsNetherlands
-
Yusuf ShiebaCompletedAcute Type A Aortic DissectionEgypt
-
Fuji Systems CorporationAvaniaActive, not recruitingAortic Aneurysm | Aortic Dissection | Aortic Arch Aneurysm | Aortic Arch; Aneurysm, DissectingGermany, Netherlands
-
The Second Hospital of Nanjing Medical UniversityRecruitingType A Aortic DissectionChina
-
West China HospitalUnknownHypothermia | Circulatory Arrest | Type A Aortic DissectionChina
-
Hospital Civil de GuadalajaraActive, not recruitingChronic Kidney Disease (CKD) Stage 5 | Peritoneal Dialysis AccessMexico
-
University of Tennessee Graduate School of MedicineShockwave Medical, Inc.Recruiting
-
University of SarajevoCompletedBrain Injuries | Subarachnoid HemorrhageBosnia and Herzegovina